These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8223146)

  • 1. Thrombosis induced by endothelin (ET-1) and carrageenin in rats treated with indomethacin and propionyl carnitine.
    Bertelli A; Bertelli AA; Galmozzi G; Giovannini L; Mian M
    Drugs Exp Clin Res; 1993; 19(2):75-8. PubMed ID: 8223146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potentiating effect of propionyl carnitine on prostacycline prevention of thrombosis induced by endothelin (ET-1) and K-carrageenin.
    Bertelli A; Bertelli AA; Giovannini L
    Drugs Exp Clin Res; 1994; 20(1):7-11. PubMed ID: 7924894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role of propionyl carnitine in vascular disorders experimentally induced by endothelin (ET-1) serotonin and K-carrageenin.
    Bertelli A; Giovannini L; Galmozzi G; Bertelli AA
    Drugs Exp Clin Res; 1993; 19(1):7-11. PubMed ID: 8223141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of histamine release and pressure increase induced by endothelin (ET-1) in isolated rat kidneys treated with propionyl carnitine.
    Bertelli A; Giovannini L; Bertelli AA
    Drugs Exp Clin Res; 1992; 18(8):349-53. PubMed ID: 1284047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-propionyl carnitine reduces toxicity correlated to cyclosporine-induced intracellular ATP concentrations.
    Giovannini L; Migliori M; De Pietro S; Taccola D; Panichi V; Bertelli AA; Bertelli A
    Drugs Exp Clin Res; 1999; 25(4):173-7. PubMed ID: 10442274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of propionyl-L-carnitine against PAF-induced rat paw oedema.
    Caruso A; Cutuli VM; De Bernardis E; Leonardi G; Amico-Roxas M
    Pharmacol Res; 1995 Jan; 31(1):67-72. PubMed ID: 7784308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine-induced lipid peroxidation and propionyl carnitine protective effect.
    Longoni B; Giovannini L; Migliori M; Bertelli AA; Bertelli A
    Int J Tissue React; 1999; 21(1):7-11. PubMed ID: 10463135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
    Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-carnitine and propionyl-L-carnitine improve endothelial dysfunction in spontaneously hypertensive rats: different participation of NO and COX-products.
    Bueno R; Alvarez de Sotomayor M; Perez-Guerrero C; Gomez-Amores L; Vazquez CM; Herrera MD
    Life Sci; 2005 Sep; 77(17):2082-97. PubMed ID: 15958269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplerotic effect of propionyl carnitine in rat heart mitochondria.
    Tassani V; Cattapan F; Magnanimi L; Peschechera A
    Biochem Biophys Res Commun; 1994 Mar; 199(2):949-53. PubMed ID: 8135845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endothelin-1 in carrageenin-induced inflammation.
    Bertelli A; Clerico A; Chicca A; Giovannini L; Gorio A; Romano MA
    Int J Tissue React; 1992; 14(5):225-30. PubMed ID: 1300308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new therapeutic proposal for intermittent claudication. Propionyl-L-carnitine: new indications concerning mechanism of action].
    Brevetti G; Martone VD; Corrado S; Silvestro A; Di Donato AM; Di Iorio A
    Minerva Cardioangiol; 1998 Sep; 46(9):299-300. PubMed ID: 10021852
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective action of propionyl-L-carnitine on toxicity induced by hyperbaric oxygen.
    Bertelli A; Giovannini L; Mian M; Spaggiari PG
    Drugs Exp Clin Res; 1990; 16(10):527-30. PubMed ID: 2100735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of L-propionyl carnitine on in-vitro membrane alteration of sickle-cell anaemia erythrocytes.
    Ronca F; Palmieri L; Malengo S; Bertelli A
    Int J Tissue React; 1994; 16(4):187-94. PubMed ID: 7797405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
    Dal Lago A; De Martini D; Flore R; Gaetani E; Gasbarrini A; Gerardino L; Pola R; Santoliquido A; Serricchio M; Tondi P; Nolfe G
    Drugs Exp Clin Res; 1999; 25(1):29-36. PubMed ID: 10337502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis.
    Perna AF; Acanfora F; Satta E; Lombardi C; Capasso R; Ingrosso D; De Santo NG
    J Nephrol; 2007; 20(1):63-5. PubMed ID: 17347975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrageenin-induced thrombosis in the rat and mouse as a test model of substances influencing thrombosis.
    Bekemeier H; Hirschelmann R; Giessler AJ
    Biomed Biochim Acta; 1984; 43(8-9):S347-50. PubMed ID: 6517902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological and ultrastructural changes of cardiomyocytes in experimental rats with tail thrombosis following subplantar application of carrageenin.
    Kod'ousek R; Jezdínský J; Krajcí D
    Med Princ Pract; 2007; 16(5):360-6. PubMed ID: 17709924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison between L-propionyl carnitine and physical-rehabilitative exercise in diabetics with obliterative arteriopathy of the legs (Fontaine's stage IIa)].
    Costanza G; Di Salvo A; Barone G; Verruso G; Zamueli M; Marchese G
    Minerva Cardioangiol; 1999 Dec; 47(12):649-50. PubMed ID: 10670244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.